CSS LLC’s Mustang Bio MBIO Stock Holding History

CSS LLC’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-14	Closed	-$43K	–	704
2019 Q4	$43K	Hold	14	–	–	﹤0.01%	606
2019 Q3	$35K	Hold	14	–	–	﹤0.01%	557
2019 Q2	$39K	Buy	+14	New	+$40K	﹤0.01%	702

Other funds holding MBIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

CSS LLC's MBIO Position: Q1 2020 in Review

CSS LLC sold out of Mustang Bio (MBIO) in Q1 2020, closing a stake of 14 shares — an estimated $43K sold.

CSS LLC first reported a position in MBIO in Q2 2019 and held it in 3 quarters. The position peaked at $43K in Q4 2019. 64 funds tracked by Wall St. Rank hold MBIO as of Q1 2020.

CSS LLC reported no remaining Mustang Bio position as of Q1 2020 after selling out during the quarter.
CSS LLC sold 14 Mustang Bio shares in Q1 2020, an estimated $43K.
CSS LLC first reported a position in Mustang Bio in Q2 2019 and held it in 3 quarters.
CSS LLC's Mustang Bio position peaked at $43K in Q4 2019.
64 funds tracked by Wall St. Rank held Mustang Bio as of Q1 2020.

Based on CSS LLC's 13F filing for Q1 2020, filed 15 May 2020.